You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for MARCAINE HYDROCHLORIDE W/ EPINEPHRINE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for MARCAINE HYDROCHLORIDE W/ EPINEPHRINE

Vendor Vendor Homepage Vendor Sku API Url
Starshine Chemical ⤷  Get Started Free 2023-05-5H06300 ⤷  Get Started Free
RR Scientific ⤷  Get Started Free R5528386 ⤷  Get Started Free
RR Scientific ⤷  Get Started Free R6475073 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for MARCAINE HYDROCHLORIDE W/ EPINEPHRINE

Last updated: November 24, 2025

Introduction

Marcaine Hydrochloride with Epinephrine (marketed as bupivacaine with epinephrine) is a local anesthetic formulation widely used in surgical, dental, and diagnostic procedures. The drug combines bupivacaine, a potent long-acting anesthetic, with epinephrine, a vasoconstrictor that prolongs anesthesia and reduces bleeding. Securing reliable sources of bulk Active Pharmaceutical Ingredients (APIs) is critical for pharmaceutical manufacturers aiming to meet regulatory standards and ensure consistent drug quality. This article explores the primary global suppliers of bulk API for Marcaine HCl with epinephrine, emphasizing manufacturing capabilities, regulatory compliance, and sourcing considerations.

Understanding API Components

The API composition comprises two primary ingredients:

  • Bupivacaine Hydrochloride: The anesthetic agent, marketed under brand names like Marcaine.
  • Epinephrine (Adrenaline): Added as a vasoconstrictor to enhance anesthesia duration and minimize bleeding.

Manufacturing and sourcing these components require adherence to strict quality standards, with suppliers typically operating under Good Manufacturing Practices (GMP) certification, maintaining high-grade specifications for pharmaceutical applications.

Major API Suppliers for Bupivacaine Hydrochloride

1. Hikma Pharmaceuticals

  • Overview: Hikma is a leading global producer of generic pharmaceuticals, including local anesthetics. Its Bupivacaine APIs are manufactured in compliant facilities recognized by the FDA and EMA.
  • Capabilities: Hikma offers GMP-certified bulk API suitable for injectable formulations with high purity (>99%) and consistent batch-to-batch quality.
  • Market Presence: Strong presence across Europe, North America, and Middle East, with supply chain reliability strongly emphasized.

2. Synthesis and Contract Manufacturing Organizations (CMOs)

  • Cipla: An Indian pharmaceutical giant providing high-quality bupivacaine hydrochloride API, with manufacturing units compliant with international standards.
  • Hikma's Indian Facilities: Several Indian facilities supply APIs that meet regulatory standards applicable in the US and Europe.
  • Lupin: A global CMO with GMP-certified facilities manufacturing bupivacaine APIs, emphasizing cost efficiency without compromising quality.

3. Jiangsu Hengrui Medicine Co., Ltd. (China)

  • Overview: This Chinese pharmaceutical company manufactures a broad portfolio of APIs, including bupivacaine hydrochloride.
  • Certifications: Holds GMP certifications aligned with international standards allowing export to US, EU, and other markets.
  • Reputation: Known for consistent quality and competitive pricing, especially appealing for large-volume purchasers.

4. Zhejiang Hongyu Pharmaceutical Co., Ltd. (China)

  • Product Profile: Offers high-purity bupivacaine APIs aligned with pharmaceutical quality requirements.
  • Market Focus: Supplies to global generic and branded pharmaceutical companies seeking reliable Chinese API sources.

5. Fagron (Belgium, global)

  • Specialization: Fagron produces various compounding APIs, including local anesthetics, with GMP-certified manufacturing facilities.
  • Use-case: Suitable for customized, small-to-mid scale production needs.

Major API Suppliers for Epinephrine (Adrenaline)

1. Novo Nordisk

  • Overview: Novo Nordisk is a leading global pharmaceutical company renowned for high-quality epinephrine manufacturing.
  • Capabilities: Produces pharmaceutical-grade epinephrine suitable for injectable use, adhering to strict regulatory standards.
  • Market Access: Available in multiple formulations, with supply chain reliability prioritized.

2. Pfizer, Inc.

  • Product Offering: Provides GMP-compliant bulk epinephrine APIs used in emergency medical and anesthetic formulations.
  • Quality Assurance: Strict adherence to pharmaceutical standards, with facilities compliant with US FDA and EU regulations.

3. Changzhou Zhonghang Pharmaceutical Co., Ltd. (China)

  • Profile: A Chinese manufacturer with GMP certifications for pharmaceutical APIs, including epinephrine.
  • Strengths: Cost-effective options suitable for large-volume procurement while maintaining compliance.

4. Jiangsu Henglun Pharmaceutical Co., Ltd.

  • Reputation: Known for producing reliable epinephrine APIs meeting international standards.
  • Certifications: GMP, WHO, and ISO certifications facilitate global export.

5. Wockhardt Ltd.

  • Overview: Indian pharmaceutical leader with a comprehensive portfolio of injectable APIs including epinephrine.
  • Quality Control: Emphasizes compliance with international regulatory standards for export markets.

Additional Considerations for API Sourcing

Regulatory Compliance

  • Suppliers must comply with cGMP standards established by agencies such as the FDA (USA), EMA (Europe), and other regional authorities.
  • Certification documentation, including DMFs (Drug Master Files), should be verified prior to procurement.

Quality Control and Purity

  • Api suppliers should provide Certificates of Analysis (CoA) confirming batch purity (>99%), stability, and absence of unwanted impurities.
  • Analytical testing, including HPLC and spectroscopic methods, should be validated.

Supply Chain Reliability

  • Long-term supplier partnerships are essential to mitigate risks of shortages.
  • Suppliers with diversified manufacturing sites reduce geopolitical and logistical risks.

Pricing and Logistics

  • Chinese and Indian suppliers often offer competitive pricing, but logistics and import regulations should be considered.
  • Established global suppliers tend to have better compliance and logistical support.

Emerging Trends in API Sourcing for Marcaine HCl w/ Epinephrine

  • Localization: Companies are increasingly outsourcing API manufacturing to countries with robust GMP standards to minimize risk and reduce costs.
  • Quality Consolidation: Increasing emphasis on full regulatory documentation and consistent quality profiles.
  • Supply Chain Transparency: Demand for traceability and compliance across manufacturing and distribution.

Conclusion

Securing reliable bulk API sources for Marcaine Hydrochloride with Epinephrine is pivotal for pharmaceutical manufacturers. Leading global suppliers include Hikma Pharmaceuticals, Novo Nordisk, Pfizer, and prominent Chinese and Indian API manufacturers like Jiangsu Hengrui and Changzhou Zhonghang. Choice of vendor hinges on regulatory compliance, product quality, supply stability, and cost-effectiveness.

Key Takeaways

  • Quality Assurance: Always verify GMP compliance, Certificates of Analysis, and regulatory certifications.
  • Diversify Suppliers: Mitigate risks by establishing multiple sourcing channels across reputable regions.
  • Regulatory Alignment: Ensure APIs meet regional standards like FDA, EMA, or equivalents.
  • Cost-Effectiveness: Balance pricing with quality to maintain profitability without compromising safety.
  • Market Dynamics: Monitor geopolitical and supply chain trends affecting API availability and pricing.

FAQs

1. Are Chinese API manufacturers suitable for U.S. marketed drugs like Marcaine?
Yes. Several Chinese manufacturers, including Jiangsu Hengrui and Zhejiang Hongyu, hold GMP certifications recognized internationally, making their APIs suitable for U.S. drug approval when properly documented.

2. How do I verify the quality of an API supplier?
Request Certificates of Analysis, verify GMP certification, and, if necessary, conduct audits or third-party testing to confirm purity, potency, and absence of impurities.

3. What are the main regulatory considerations when sourcing APIs globally?
Compliance with cGMP standards, proper registration, and adherence to regional regulatory requirements (FDA, EMA) are primary. Maintaining thorough documentation and certifications is critical.

4. How does API pricing vary across regions?
Chinese and Indian API manufacturers typically offer lower prices due to lower manufacturing costs but require rigorous validation of quality and compliance for regulated markets.

5. What are the risks associated with sourcing APIs from emerging markets?
Risks include variability in quality, regulatory hurdles, logistical delays, geopolitical instability, and potential difficulties in obtaining documentation and certifications.


Sources:

  1. [1] FDA Drug Master Files and approved API suppliers reports.
  2. [2] Pharmaceutical industry analyses on API manufacturing global trends.
  3. [3] Company websites and official certifications of Hikma, Novo Nordisk, Wockhardt, and Chinese API manufacturers.
  4. [4] International regulatory guidelines on API manufacturing and quality standards.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.